Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Journal of Animal Science
|
June 1, 1996
Effect of fungal biomass in alfalfa hay on intake and total tract digestion in growing beef calves
C V Bossuyt, K M Wittenberg, G H Crow
Ultramicroscopy
|
January 5, 2002
Early detection of cytotoxic events between hepatic natural killer cells and colon carcinoma cells as probed with the atomic force microscope
F Braet, D Vermijlen, V Bossuyt, et al.
The Journal of Hospital Infection
|
November 1, 1996
Changes in major populations of methicillin-resistant Staphylococcus aureus in Belgium
C Wildemauwe, C Godard, R Vanhoof, et al.
International Journal of Surgical Pathology
|
November 8, 2005
Remarkably high frequency of EGFR expression in breast carcinomas with squamous differentiation
V Bossuyt, O Fadare, M Martel, et al.
Human Molecular Genetics
|
February 19, 2021
Loss of nuclear UBE3A activity is the predominant cause of Angelman syndrome in individuals carrying UBE3A missense mutations
Stijn N V Bossuyt, A Mattijs Punt, Ilona J de Graaf, et al.
Molecular Genetics & Genomic Medicine
|
September 5, 2020
A novel UBE3A sequence variant identified in eight related individuals with neurodevelopmental delay, results in a phenotype which does not match the clinical criteria of Angelman syndrome
Amber Geerts-Haages, Stijn N V Bossuyt, Inge den Besten, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 12, 2018
Immunological differences between primary and metastatic breast cancer
B Szekely, V Bossuyt, X Li, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 29, 2015
Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration
V Bossuyt, E Provenzano, W F Symmans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 13, 2023
Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial
L M Spring, S M Tolaney, G Fell, et al.
Nature Neuroscience
|
June 26, 2019
Loss of nuclear UBE3A causes electrophysiological and behavioral deficits in mice and is associated with Angelman syndrome
Rossella Avagliano Trezza, Monica Sonzogni, Stijn N V Bossuyt, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Journal of Animal Science
|
June 1, 1996
Effect of fungal biomass in alfalfa hay on intake and total tract digestion in growing beef calves
C V Bossuyt, K M Wittenberg, G H Crow
Ultramicroscopy
|
January 5, 2002
Early detection of cytotoxic events between hepatic natural killer cells and colon carcinoma cells as probed with the atomic force microscope
F Braet, D Vermijlen, V Bossuyt, et al.
The Journal of Hospital Infection
|
November 1, 1996
Changes in major populations of methicillin-resistant Staphylococcus aureus in Belgium
C Wildemauwe, C Godard, R Vanhoof, et al.
International Journal of Surgical Pathology
|
November 8, 2005
Remarkably high frequency of EGFR expression in breast carcinomas with squamous differentiation
V Bossuyt, O Fadare, M Martel, et al.
Human Molecular Genetics
|
February 19, 2021
Loss of nuclear UBE3A activity is the predominant cause of Angelman syndrome in individuals carrying UBE3A missense mutations
Stijn N V Bossuyt, A Mattijs Punt, Ilona J de Graaf, et al.
Molecular Genetics & Genomic Medicine
|
September 5, 2020
A novel UBE3A sequence variant identified in eight related individuals with neurodevelopmental delay, results in a phenotype which does not match the clinical criteria of Angelman syndrome
Amber Geerts-Haages, Stijn N V Bossuyt, Inge den Besten, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 12, 2018
Immunological differences between primary and metastatic breast cancer
B Szekely, V Bossuyt, X Li, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 29, 2015
Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration
V Bossuyt, E Provenzano, W F Symmans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 13, 2023
Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial
L M Spring, S M Tolaney, G Fell, et al.
Nature Neuroscience
|
June 26, 2019
Loss of nuclear UBE3A causes electrophysiological and behavioral deficits in mice and is associated with Angelman syndrome
Rossella Avagliano Trezza, Monica Sonzogni, Stijn N V Bossuyt, et al.
Page
of 1